- ISIN
- US40145W1018
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- Sep 26, 2024
Highlights
- Market Cap
- $2.50B
- Enterprise Value
- $2.45B
- EPS (TTM)
- $0.83
- PE Ratio
- 47.36
- PEG Ratio
- 1.14
- Total Revenue (TTM)
- $1.46B
- Gross Profit (TTM)
- $294.00M
- EBITDA (TTM)
- $101.87M
- Year Range
- $19.30 - $44.00
- Target Price
- $38.00
- ROA (TTM)
- 12.43%
- ROE (TTM)
- 22.83%
- Avg. Volume (1M)
- 320K
- Avg. Volume Value (1M)
- $12.97M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
GRDN Performance Chart
Guardian Pharmacy Services, Inc (GRDN) is up 31.4% since the beginning of the year. At $40 per share, GRDN is trading 10.2% below its 52-week high of $44.
Loading charts...
Compare this symbol against anything
Returns By Period
Guardian Pharmacy Services, Inc (GRDN) has returned 31.37% so far this year and 94.44% over the past 12 months.
Guardian Pharmacy Services, Inc
- 1D
- -4.05%
- 1M
- -5.88%
- 6M
- 30.89%
- YTD
- 31.37%
- 1Y
- 94.44%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 72.60%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
GRDN Monthly Returns History
Based on dividend-adjusted daily data since Sep 26, 2024, GRDN's average daily return is +0.26%, while the average monthly return is +5.21%. At this rate, an investment would double in approximately 1.1 years.
Historically, 70% of months were positive and 30% were negative. The best month was Nov 2024 with a return of +39.3%, while the worst month was Dec 2024 at -18.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 1 months.
On a daily basis, GRDN closed higher 54% of trading days. The best single day was Aug 12, 2025 with a return of +13.8%, while the worst single day was May 21, 2025 at -16.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.37% | 10.96% | 12.38% | -1.49% | 4.42% | 8.08% | -5.59% | 31.37% | |||||
| 2025 | 12.59% | -12.32% | 6.30% | 17.78% | -15.46% | 0.66% | -1.92% | 26.41% | -0.72% | 6.90% | 4.42% | 2.77% | 48.52% |
| 2024 | 16.18% | 6.61% | 39.25% | -18.77% | 40.11% |
Benchmark Metrics
Guardian Pharmacy Services, Inc has an annualized alpha of 71.35%, beta of 0.78, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since September 26, 2024.
- This stock captured 202.65% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -146.39%) - a profile typical of hedging or uncorrelated assets.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 71.35%
- Beta
- 0.78
- R²
- 0.07
- Upside Capture
- 202.65%
- Downside Capture
- -146.39%
Return for Risk
Risk / Return Rank
GRDN ranks 91 for risk / return — above 91% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Guardian Pharmacy Services, Inc (GRDN) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GRDN | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.71 | ||
| Sortino ratioReturn per unit of downside risk | +0.77 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.25 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 3.94 | 2.00 | +1.94 |
| Martin ratioReturn relative to average drawdown | 11.46 | 8.49 | +2.97 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Guardian Pharmacy Services, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Guardian Pharmacy Services, Inc was 27.21%, occurring on Mar 6, 2025. Recovery took 40 trading sessions.
The current Guardian Pharmacy Services, Inc drawdown is 8.92%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-27.21%Mar 2025 | 2mo 23d | 1mo 27d | 4mo 20dDec 2024 - May 2025 | 2025 selloff2025 |
-25.83%Jun 2025 | 28d | 2mo 17d | 3mo 15dMay 2025 - Sep 2025 | 2025 selloff2025 |
-22.74%Oct 2025 | 28d | 1mo 2d | 2moSep 2025 - Nov 2025 | — |
-14.33%Jan 2026 | 2mo 4d | 17d | 2mo 21dNov 2025 - Feb 2026 | — |
-14.12%May 2026 | 1mo 2d | 23d | 1mo 25dApr 2026 - Jun 2026 | — |
Drawdown Indicators
| GRDN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -27.21% | -56.78% | +29.57% |
Max Drawdown (1Y)Largest decline over 1 year | -22.74% | -9.10% | -13.64% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -8.92% | -1.58% | -7.34% |
Average DrawdownAverage peak-to-trough decline | -9.44% | -10.70% | +1.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.81% | 2.14% | +5.67% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Guardian Pharmacy Services, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Guardian Pharmacy Services, Inc is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for GRDN, comparing it with other companies in the Medical Care Facilities industry. Currently, GRDN has a P/E ratio of 47.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for GRDN compared to other companies in the Medical Care Facilities industry. GRDN currently has a PEG ratio of 1.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for GRDN relative to other companies in the Medical Care Facilities industry. Currently, GRDN has a P/S ratio of 1.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for GRDN in comparison with other companies in the Medical Care Facilities industry. Currently, GRDN has a P/B value of 10.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with GRDN
Add Guardian Pharmacy Services, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with GRDN